Atlas Trials

Safely Delivered Targeted High-dose Irradiation Followed by Adoptive Immunotherapy with Regulatory and Conventional T Cells to Increase Potency of Hematopoietic Stem Cell Transplantation in High-risk Acute Leukemia

Clinical trial NCT06845592 · RECRUITING

Trial details

NCT number
NCT06845592
Sponsor
University Of Perugia
Status
RECRUITING
Phase
Not Applicable
Study type
INTERVENTIONAL
Acute Myeloid Leukaemia (AML)Acute Lymphoblastic Leukemia ALLHigh Risk LeukaemiaLeukaemia Relapse
Start date
2025-02-25
Primary completion
2029-01-01
Enrollment
51

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.